CLINICAL_TRIALS trial_result · 2019-07-18

Clinical Trial Update: Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis [Phase 2]

Phase 2 trial assessing long-term safety, tolerability, and efficacy of AMG 827 in psoriasis was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 2 | Status: TERMINATED | Results posted: 2019-07-18